Skip to content

Released May 6, 2021, after the close

10-Q filed May 6, 2021, 36 days after period end · 0001564590-21-025060

Q1 2021 · 10-Q
Revenue—
Net Income-$27.20MN/M vs Q1 2020N/M vs Q4 2020
EPS Diluted-$0.69N/M vs Q1 2020N/M vs Q4 2020
Operating Income-$27,258,000N/M
Operating Cash Flow-$33,344,000N/M
Free Cash Flowderived-$36,422,000N/M

What the release said

The release

Same quarter

MetricQ1 2021Q1 2020Q1 2019Q1 2018
Revenue—$4.08M$3.89M$3.57M
Net Income-$27.20M-$26.66M-$27.05M-$16.25M
EPS Diluted-$0.69-$0.76-$1.05-$0.80

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR